{"name": "Origen Therapeutics",
 "permalink": "origen-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/origen-therapeutics",
 "homepage_url": "http://www.origentherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1997,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "650-558-6700",
 "description": "biotechnology company ",
 "created_at": "Thu Sep 17 15:50:24 UTC 2009",
 "updated_at": "Thu Sep 17 15:53:53 UTC 2009",
 "overview": "\u003Cp\u003EOrigen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also develops a technology platform based on the genetic engineering of chicken embryonic cells, which can be genetically modified in such a way that the introduced genes are stably expressed in adult birds. Origen Therapeutics, Inc. was incorporated in 1997 and is based in Burlingame, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       85],
      "assets/images/resized/0006/0055/60055v1-max-150x150.png"],
     [[200,
       114],
      "assets/images/resized/0006/0055/60055v1-max-250x250.png"],
     [[200,
       114],
      "assets/images/resized/0006/0055/60055v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "http://deals.venturebeat.com/2007/10/03/chicken-antibody-maker-origen-gets-2m-grant/",
    "source_description": "Chicken-antibody maker Origen gets $2M grant",
    "raised_amount": 2000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 10,
    "funded_day": 3,
    "investments":
     [{"company":
        {"name": "National Institute of Standards and Technology",
         "permalink": "national-institute-of-standards-and-technology",
         "image":
          {"available_sizes":
            [[[100,
               46],
              "assets/images/resized/0006/0056/60056v1-max-150x150.png"],
             [[100,
               46],
              "assets/images/resized/0006/0056/60056v1-max-250x250.png"],
             [[100,
               46],
              "assets/images/resized/0006/0056/60056v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "1450 Rollins Road",
    "address2": "",
    "zip_code": "94010",
    "city": "Burlingame",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}